Results 121 to 130 of about 4,106,944 (201)

Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune Response. [PDF]

Rev Med Virol
Kaplan D, Blyth E, Sutrave G, Yong MK, Gottlieb DJ, Abendroth A, Slobedman B, Stern L.   +7 more
europepmc   +1 more source

Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences. [PDF]

Front Immunol
Schwingen NR, Meretuk L, Aigner M, Kretschmann S, Scholz JK, Gsottberger F, Harrer DC, Dingfelder J, Lutzny-Geier G, Kharboutli S, Mackensen A, Müller F, Völkl S.   +12 more
europepmc   +1 more source

CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting. [PDF]

J Hematol Oncol
Geng C, Chen W, Zhu HH.
europepmc   +1 more source

Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy. [PDF]

Cancer Res
Wang R, Yu J, Caligiuri MA, Ma S.
europepmc   +1 more source

Cop Car

, 2006
Zhou, Ming Q.
core  

BATF3 regulates differentiation of CD8⁺ T lymphocytes and memory differentiation program. [PDF]

Life Sci Alliance
Umemura K, Kojima Y, Julamanee J, Okuno Y, Takeuchi Y, Ohara F, Kuwano S, Adachi Y, Hanajiri R, Terakura S, Kiyoi H.   +10 more
europepmc   +1 more source

Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling. [PDF]

Ann Hematol
Maggi R, Ricciuti EF, Galli E, Sorà F, Fiorita A, Sica S, Chiusolo P.   +6 more
europepmc   +1 more source

Advancements and expanding applications of CAR-T cell therapy. [PDF]

Front Immunol
Zhang X, Liu ZC, Luo LJ, Wu YW, Cui XG, Chen L.   +5 more
europepmc   +1 more source